SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare - Quaterly Results

03 Feb 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 18303.00 millions against Rs. 19188.00 millions recorded during the year-ago period.A comparatively good net profit growth of 40.41% to Rs. 1970.00 millions was reported for the quarter ended December 2021 compared to Rs. 1403.00 millions of previous same quarter.The Operating Profit of the company witnessed a decrease to 3845.00 millions from 5231.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 18303.00 19188.00 -4.61 59626.00 57716.00 3.31 77904.00 63474.00 22.73
Other Income 259.00 250.00 3.60 1250.00 1058.00 18.15 789.00 8494.00 -90.71
PBIDT 3845.00 5231.00 -26.50 15855.00 18207.00 -12.92 23980.00 22725.00 5.52
Interest 246.00 156.00 57.69 929.00 504.00 84.33 709.00 2339.00 -69.69
PBDT 3599.00 3200.00 12.47 11733.00 15828.00 -25.87 21396.00 19866.00 7.70
Depreciation 1200.00 1131.00 6.10 3559.00 3361.00 5.89 4511.00 4289.00 5.18
PBT 2399.00 2069.00 15.95 8174.00 12467.00 -34.43 16885.00 15577.00 8.40
TAX 429.00 666.00 -35.59 2064.00 2352.00 -12.24 2123.00 2041.00 4.02
Deferred Tax 183.00 24.00 662.50 241.00 -126.00 -291.27 -910.00 400.00 -327.50
PAT 1970.00 1403.00 40.41 6110.00 10115.00 -39.59 14762.00 13536.00 9.06
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 21.01 27.26 -22.94 26.59 31.55 -15.71 30.78 35.80 -14.02

Zydus Lifesciences Share Price

927.15 -19.95 (-2.11%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×